Key statistics
As of last trade Immutep Ltd (YP1B:FRA) traded at 0.206, -17.60% below its 52-week high of 0.25, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.206 |
|---|---|
| High | 0.206 |
| Low | 0.206 |
| Bid | 0.212 |
| Offer | 0.246 |
| Previous close | 0.216 |
| Average volume | 45.00 |
|---|---|
| Shares outstanding | 1.47bn |
| Free float | 1.20bn |
| P/E (TTM) | -- |
| Market cap | 567.38m AUD |
| EPS (TTM) | -0.0573 AUD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:25 GMT.
More ▼
Announcements
- Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
- Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
- Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
